Literature DB >> 18661157

[Cytokine regulation and pain. Results of experimental and clinical research].

N Uçeyler1, C Sommer.   

Abstract

Cytokines are soluble peptides and proteins that are predominantly produced and secreted by immune cells. In numerous animal experiments the endogenous increase or application of exogenous pro-inflammatory cytokines is associated with pain behavior. In turn, cytokine inhibitors reduce such pain behavior in inflammatory and neuropathic pain models. Several clinical studies point out that cytokines are also important in different human pain states. Several chronic pain syndromes are associated with systemic pro-inflammatory cytokine profiles. In some pain syndromes these pro-inflammatory profiles are accompanied by a lack of analgesic anti-inflammatory cytokines. Numerous case reports and open clinical studies, but also some controlled trials show successful analgesic treatment using cytokine inhibitors. The following review article summarizes the main data of animal experiments and clinical trials concerning the role of cytokines in pain and the potential importance of cytokine modulation in pain treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661157     DOI: 10.1007/s00482-008-0706-0

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  103 in total

1.  Successful treatment of CRPS 1 with anti-TNF.

Authors:  Frank J P M Huygen; Sjoerd Niehof; Freek J Zijlstra; P Martin van Hagen; Paul L A van Daele
Journal:  J Pain Symptom Manage       Date:  2004-02       Impact factor: 3.612

2.  Interleukin-1 activity in lesioned peripheral nerve.

Authors:  S Rotshenker; S Aamar; V Barak
Journal:  J Neuroimmunol       Date:  1992-07       Impact factor: 3.478

3.  Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS.

Authors:  Guillermo M Alexander; M A van Rijn; J J van Hilten; Marielle J Perreault; Robert J Schwartzman
Journal:  Pain       Date:  2005-08       Impact factor: 6.961

Review 4.  Biological basis of the behavior of sick animals.

Authors:  B L Hart
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

5.  Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system.

Authors:  A Inoue; K Ikoma; N Morioka; K Kumagai; T Hashimoto; I Hide; Y Nakata
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

6.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

Authors:  Flobert Y Tanga; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

7.  Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10.

Authors:  Erin D Milligan; Stephen J Langer; Evan M Sloane; Lin He; Julie Wieseler-Frank; Kevin O'Connor; David Martin; John R Forsayeth; Steven F Maier; Kirk Johnson; Raymond A Chavez; Leslie A Leinwand; Linda R Watkins
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

8.  Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model.

Authors:  J A DeLeo; M D Rutkowski; A K Stalder; I L Campbell
Journal:  Neuroreport       Date:  2000-02-28       Impact factor: 1.837

9.  Mechanism of interleukin-1 beta-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats.

Authors:  Lingfei Hou; Wenjing Li; Xian Wang
Journal:  J Neurosci Res       Date:  2003-07-15       Impact factor: 4.164

10.  Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome.

Authors:  Christian Schinkel; Andreas Gaertner; Johannes Zaspel; Siegfried Zedler; Eugen Faist; Matthias Schuermann
Journal:  Clin J Pain       Date:  2006 Mar-Apr       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.